Physician profile
Michael Liu
NPI 1285600981
$732.62
in general payments reported to CMS, 2019-2025
13 companies · $38.00 in 2025
The $38.00 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.64 · 2020: $68.82 · 2021: $108 · 2022: $215 · 2023: $134 · 2024: $95.91 · 2025: $38.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $148.77 | 2020-2022 | |
| Pfizer INC. | $123.52 | 2019-2024 | |
| Glaxosmithkline, LLC. | $115.36 | 2022-2025 | Bexsero, Rotarix, Pediarix |
| Merck Sharp & Dohme LLC | $107.62 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi Pasteur INC. | $44.11 | 2020-2022 | |
| Cranial Technologies, INC | $44.04 | 2019-2021 | |
| Ultragenyx Pharmaceutical INC. | $38.21 | 2022-2023 | |
| Ironshore Pharmaceuticals INC. | $27.24 | 2019 | |
| Cognoa, INC. | $26.86 | 2022 | |
| Meridian Bioscience INC. | $18.98 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $13.60 | 2022 | |
| Aytu Biopharma, INC. | $12.45 | 2022 | |
| Aimmune Therapeutics, INC. | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.